SFRP4 and osteopetrosis: The comprehensive understanding of the SFRP4-mediated bone developmental process could contribute to future therapeutic approaches of the diseases associated with either reduced or increased bone mineral density, facilitating, for instance, treatment of osteoporosis and osteopetrosis.